View Clinical Trial (Medical Research Study)
A Study in Healthy Volunteers to Assess Effect of AZD6765 on Midazolam Blood Levels - NCT01069822-(Clinical Trial 562035)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Overland Park |
|
State:
|
|
KS |
| Zip Code: |
|
|
| Conditions: |
|
Healthy |
| Purpose: |
|
The main purpose of this study is to evaluate the effect repeated doses of AZD6765 (a drug
being developed for the treatment of patients with severe major depressive disorder) has on
the PK (pharmacokinetic) profile of Midazolam. (The PK profile is how the drug leaves your
body and acts in the body.)
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- BMI between 19-30
Exclusion Criteria:
- Significant result for C-SSRS at screening or baseline
- Single arm preference for IV procedures |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 21, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|